Glucose Health Stock Performance
GLUC Stock | USD 0.16 0.01 6.67% |
Glucose Health holds a performance score of 5 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Glucose Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Glucose Health is expected to be smaller as well. Use Glucose Health value at risk and the relationship between the expected short fall and market facilitation index , to analyze future returns on Glucose Health.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Glucose Health are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Glucose Health exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Glucose |
Glucose Health Relative Risk vs. Return Landscape
If you would invest 17.00 in Glucose Health on September 17, 2024 and sell it today you would lose (1.00) from holding Glucose Health or give up 5.88% of portfolio value over 90 days. Glucose Health is currently generating 1.1197% in daily expected returns and assumes 16.4583% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Glucose, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Glucose Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Glucose Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Glucose Health, and traders can use it to determine the average amount a Glucose Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.068
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | GLUC | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
16.46 actual daily | 96 96% of assets are less volatile |
Expected Return
1.12 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Glucose Health is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Glucose Health by adding it to a well-diversified portfolio.
Glucose Health Fundamentals Growth
Glucose Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Glucose Health, and Glucose Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Glucose Pink Sheet performance.
Return On Equity | -0.5 | |||
Return On Asset | -0.28 | |||
Profit Margin | (0.32) % | |||
Operating Margin | (0.32) % | |||
Current Valuation | 1.16 M | |||
Shares Outstanding | 4.55 M | |||
Price To Earning | (1.99) X | |||
Price To Sales | 3.42 X | |||
Revenue | 1.11 M | |||
EBITDA | (336.06 K) | |||
Cash And Equivalents | 569.39 K | |||
Cash Per Share | 0.04 X | |||
Total Debt | 332.88 K | |||
Book Value Per Share | 0.06 X | |||
Cash Flow From Operations | (72.74 K) | |||
Earnings Per Share | (0.04) X | |||
Total Asset | 207 K | |||
Retained Earnings | (5.96 M) | |||
Current Asset | 207 K | |||
Current Liabilities | 424 K | |||
About Glucose Health Performance
By analyzing Glucose Health's fundamental ratios, stakeholders can gain valuable insights into Glucose Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Glucose Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Glucose Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas. Glucose Health operates under Packaged Foods classification in the United States and is traded on OTC Exchange.Things to note about Glucose Health performance evaluation
Checking the ongoing alerts about Glucose Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Glucose Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Glucose Health is way too risky over 90 days horizon | |
Glucose Health has some characteristics of a very speculative penny stock | |
Glucose Health appears to be risky and price may revert if volatility continues | |
Glucose Health has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 1.11 M. Net Loss for the year was (338.9 K) with loss before overhead, payroll, taxes, and interest of (2.41 K). | |
Glucose Health currently holds about 569.39 K in cash with (72.74 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. |
- Analyzing Glucose Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Glucose Health's stock is overvalued or undervalued compared to its peers.
- Examining Glucose Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Glucose Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Glucose Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Glucose Health's pink sheet. These opinions can provide insight into Glucose Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Glucose Pink Sheet analysis
When running Glucose Health's price analysis, check to measure Glucose Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glucose Health is operating at the current time. Most of Glucose Health's value examination focuses on studying past and present price action to predict the probability of Glucose Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glucose Health's price. Additionally, you may evaluate how the addition of Glucose Health to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |